Related Experiment Videos
Native and recombinant human Edg4 receptor-mediated Ca(2+) signalling.
Peter B Simpson1, Israel Ramos Villullas, Irina Schurov
1Merck Sharp & Dohme Research Laboratories, Neuroscience Research Centre, Harlow, Essex, UK. peter_simpson@merck.com
Assay and Drug Development Technologies
|April 20, 2004
Summary
We developed a new assay to study Edg4 receptor activity using cell lines. This system effectively models lysophosphatidic acid (LPA) signaling, revealing complex roles for endoplasmic reticulum and mitochondria in cellular responses.
Area of Science:
- Pharmacology
- Cell Biology
- Biochemistry
Background:
- Lysophosphatidic acid (LPA) receptors, particularly the Edg4 subtype, are widely expressed and involved in various cellular functions.
- Understanding Edg4 receptor signaling is crucial for developing targeted therapeutics.
Purpose of the Study:
- To develop and validate an assay system for assessing compound action on the Edg4 receptor.
- To investigate the signaling mechanisms underlying Edg4 activation and its downstream effects on calcium mobilization.
Main Methods:
- Stable overexpression of Edg4 in the rat hepatoma cell line Rh 7777.
- Development of a calcium (Ca2+)-based Fluorescence Live Imaging Plate Reader (FLIPR) assay.
- Comparative analysis of LPA signaling in Edg4-overexpressing cells and a human neuroblastoma cell line with endogenous Edg4 expression.
Main Results:
- The developed assay system accurately measures functional responses mediated by Edg4.
- LPA signaling via Edg4 involves both the endoplasmic reticulum and mitochondria.
- Inhibitors targeting inositol 1,4,5-triphosphate receptors partially blocked the calcium response, indicating complex signaling pathways.
Conclusions:
- The Edg4-overexpressing Rh 7777 cell line serves as a valuable model for studying Edg4 receptor pharmacology and signaling.
- The assay system facilitates the investigation of Edg4's downstream effects and potential therapeutic targets.